Form 4 for COYA Coya Therapeutics, Inc.
Accepted 2025-08-19 00:00:00 ET · period of report 2025-08-18 · accession 0001641172-25-024820 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-08-19 | 2025-08-18 | COYA | GOLDSTEIN DOV A MD | Dir | M - OptEx | $1.09 | +17.6K | 27.6K | +176% | +$19.1K |
| D | 2025-08-19 | 2025-08-18 | COYA | GOLDSTEIN DOV A MD | Dir | M - OptEx | $0.00 | -17.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 per share | 2025-08-18 | M | A | 17,557 | $1.09 | 27,557 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2025-08-18 | M | D | 17,557 | $0.00 | 0 | D | $1.09 · 2021-04-01 to 2031-03-30 | 17,557 Common Stock | (F1) This option is fully vested. |